Fundamental dimension Equity attribute | EGANLeader $5.61▼-1.23% Cap $146.8MP/E 17.4x QuantScore56/100 | BGINPeer $1.76▼-9.28% Cap $199.1MP/E -1.0x QuantScore29/100 | CMRCPeer $3.56▼-3.00% Cap $295.0MP/E -51.5x QuantScore48/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
60/100 |
28/100 |
96/100 |
Valuation Multiples, PEG & DCF upside | 97/100 | 33/100 | 62/100 |
Health Piotroski, Altman Z, leverage & liquidity | 59/100 | 31/100 | 21/100 |
Growth Revenue / earnings growth & margins | 24/100 | 25/100 | 41/100 |
Sentiment Analyst ratings, targets & revisions | 39/100 | — | 20/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 17.4x | -1.0x | -51.5x |
Forward P/E (next FY) | 105.2x | — | 11.1x |
EV / EBITDA (TTM) | 6.0x | -1.3x | 23.9x |
Price / Sales | 1.6x | 5.4x | 0.9x |
Price / Free Cash Flow | 7.2x | -1.7x | 13.7x |
PEG ratio | -0.24 | 0.01 | -1.26 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 1 / 9 | 4 / 9 |
Altman Z-Score | -0.08 (Distress) | -3.15 (Distress) | -0.54 (Distress) |
Total debt / equity | 0.03 | 0.07 | 3.19 |
Quick ratio | 1.7x | 1.1x | 2.0x |
Interest coverage | — | — | 0.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +3.1% | -77.7% | +2.8% |
Net income growth YoY | -72.5% | -368.2% | +28.4% |
Gross margin (TTM) | 73.4% | -307.8% | 76.7% |
Operating margin (FY) | 8.7% | -163.3% | -4.7% |
FCF margin (FY) | 22.5% | -253.8% | 5.5% |
5. Trailing price performancePrice change over period |
1M return | -3.8% | -5.4% | +9.2% |
3M return | -12.5% | -12.0% | +31.4% |
6M return | -25.0% | -44.8% | +18.7% |
Year to date | -45.5% | -29.9% | -13.6% |
1Y return | -59.9% | -62.6% | -26.3% |
3Y return | -4.8% | -64.5% | -61.3% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $12.81 +128.3% upside | $0.6775 -61.5% premium | $20.08 +464.0% upside |
Wall Street consensus target | $7.00 +24.8% · range $7.00–$7.00 | — — | $4.25 +19.4% · range $3.50–$5.00 |
Consensus stance | 58% Buy42% Hold-0% Sell | — | 19% Buy62% Hold19% Sell |